5240752025-07-012025-09-305240752025-09-305240752025-03-315240752025-04-012025-09-305240752025-07-012025-09-30in-capmkt:OtherExpenses1Member5240752025-04-012025-09-30in-capmkt:OtherExpenses1Member5240752025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15240752025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15240752025-07-012025-09-30RelatedPartyTransactionDomain15240752025-06-30RelatedPartyTransactionDomain15240752025-09-30RelatedPartyTransactionDomain15240752025-07-012025-09-30RelatedPartyTransactionDomain25240752025-06-30RelatedPartyTransactionDomain25240752025-09-30RelatedPartyTransactionDomain25240752025-07-012025-09-30RelatedPartyTransactionDomain35240752025-06-30RelatedPartyTransactionDomain35240752025-09-30RelatedPartyTransactionDomain35240752025-07-012025-09-30RelatedPartyTransactionDomain45240752025-06-30RelatedPartyTransactionDomain45240752025-09-30RelatedPartyTransactionDomain45240752025-07-012025-09-30RelatedPartyTransactionDomain55240752025-06-30RelatedPartyTransactionDomain55240752025-09-30RelatedPartyTransactionDomain55240752025-07-012025-09-30RelatedPartyTransactionDomain65240752025-06-30RelatedPartyTransactionDomain65240752025-09-30RelatedPartyTransactionDomain65240752025-07-012025-09-30RelatedPartyTransactionDomain75240752025-06-30RelatedPartyTransactionDomain75240752025-09-30RelatedPartyTransactionDomain75240752025-07-012025-09-30RelatedPartyTransactionDomain85240752025-06-30RelatedPartyTransactionDomain85240752025-09-30RelatedPartyTransactionDomain85240752025-07-012025-09-30RelatedPartyTransactionDomain95240752025-06-30RelatedPartyTransactionDomain95240752025-09-30RelatedPartyTransactionDomain95240752025-07-012025-09-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares524075ALBERTDAVDNOTLISTEDINE155C01010ALBERT DAVID LIMITEDMain BoardEquity2025-04-012026-03-312025-11-122025-11-01INRLakhsQuarterlySecond quarterSingle segmentPharmaceuticals2025-11-1211:00:002025-11-1215:40:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2024-03-14https://www.albertdavidindia.com/policies.phpfalsefalseNIL2025-07-012025-09-30UnauditedStandalone872413000-2143800085097500011986800010453100082130000270746000750700022282000269732000876796000-258210000-258210000719600071960000-330170000000-33017000-1853000-348700005707200010-5.79-5.7900-5.79-5.79 1. The above Unaudited Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on 12th November, 2025. The Limited Review for the quarter and half year ended 30th September, 2025 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LO&DR) Regulations, 2015. <BR> <BR> 2. The Statutory Auditors of the Company have issued an unmodified review report on the Unaudited Financial Results for the quarter and Half Year ended 30th September,2025. <BR> <BR> 3. The Company is engaged in the manufacturing of pharmaceuticals and has only one reportable segment in accordance with Ind AS-108 "Operating Segments". <BR> <BR> 4. During the quarter the Company has made payment of dividend of Rs.5.00 per equity share of Rs.10/- each, total outflow amounting to Rs.285.36 Lakhs in respect of financial year ended on 31st March, 2025. <BR> <BR> 5. Figures for the previous periods are regrouped to conform to the figures of the current period as and when required in limited context of format of financial results and disclosures thereon specified by SEBI.2025-04-012025-09-30UnauditedStandalone15780770001989240001777001000252348000203653000103328000555048000130550004616900054483800017184390005856200005856200001220300012203000046359000000046359000-36890004267000057072000108.128.12008.128.12Other Expenses269732000Other Expenses54483800094473400052125000007148000204300000175909000001590080003349170000170010001357968000514580000259084200041580100089330002431010004021500040548000333944000056092000613260003971438000532940600057072000388189400039389660003938966000876600000012290000210560005664300073543000001512420004053720001804900026696700028501600030551400099590200031652000211644000001239198000001390440000532940600013055000124440000-1424370000023660000-125600029490000-892650000-783400004616900000000-793000-927000-184880000-17684100000-3883000000-227568000-169006000000394490000-208455000000000001299000-6275800081160000000000000000000927000231500000-131725000-35475000000000000-294686000574000028308000118160000024882200048920000489200040410008933000Items that will not be reclassified to profit or loss-2476000-2476000Items that will not be reclassified to profit or loss-4930000-4930000-623000-1241000-1853000-3689000Albert David Limited******Gillander Arbuthnot and Company Limited******Company in which KMP/Director has significant influencePurchase of goods or services6000000Not Applicable24000002025-02-12240000000Albert David Limited******Strategic Marketing Solutions & Research Centre Private Limited******Company in which KMP/Director has significant influencePurchase of goods or services3500000Not Applicable12500002025-02-12125000000Albert David Limited******Medclin Research Pvt. Ltd.******Company in which KMP/Director has significant influencePurchase of goods or services2300000Not Applicable6480002025-02-1264800000Albert David Limited******Kothari Medical Centre******Trust in which KMP has significant influenceAny other transactionDonation Paid20000000Not Applicable50000002025-02-12500000000Albert David Limited******Mr. Arun Kumar Kothari******Chairman & Executive DirectorRemuneration12986000Not Applicable129860002025-05-131298600000Albert David Limited******Mrs. Prabhawati Devi Kothari******Non-Executive DirectorAny other transactionSitting fees1000000Not Applicable700002025-02-127000000Albert David Limited******Mr. Anand Vardhan Kothari******Non-Executive DirectorAny other transactionSitting fees1000000Not Applicable500002025-02-125000000Albert David Limited******Kothari Phytochemicals & Industries Ltd.******Company in which KMP/Director has significant influenceAny other transactionSale of Equity Shares50000000Not Applicable99990002025-02-12999900000Albert David Limited******PDK Family Trust******Company in which KMP/Director has significant influenceAny other transactionSale of Equity Shares50000000Not Applicable14980002025-02-1214980000033901000UnauditedtrueL B Jha & Co.true2028-01-31